Related Experiment Video
Updated: Sep 4, 2026

Targeted and Selective Treatment of Pluripotent Stem Cell-derived Teratomas Using External Beam Radiation in a Small-animal Model
Published on: February 17, 2019
Case Report: staged electron beam radiotherapy for inoperable primary ectopic abdominal extramammary Paget disease
Jiarun Jiang1, Chunxu Yang2, Qingming Xiang2
1Department of Gastroenterology, Hubei Provincial Clinical Research Center for Intestinal and Colorectal Diseases, Hubei Key Laboratory of Intestinal and Colorectal Diseases, Zhongnan Hospital of Wuhan University, Wuhan, China.
Abstract:
Extramammary Paget disease (EMPD) is a rare cutaneous adenocarcinoma that usually arises in apocrine gland-bearing areas, whereas primary ectopic EMPD of the abdominal skin is exceptionally uncommon. We report a 79-year-old woman with a five-year history of progressively enlarging eczema-like lower abdominal-pelvic skin lesions, including erosion, exudation, scaling, crusting, and pruritus, initially treated as chronic dermatitis without improvement. Histopathology showed large atypical Paget cells with focal dermal microinvasion; immunohistochemistry was positive for cytokeratin 7 (CK7) and GATA-binding protein 3 (GATA3) and negative for cytokeratin 20 (CK20) and p40, while Ki-67, a proliferation marker, showed a labeling index of approximately 60%. Because radical surgery was unsuitable, she received response-adapted two-stage electron beam radiotherapy. The first stage delivered 43.2 Gy in 12 every-other-day fractions using 12-MeV electrons, a 5-mm tissue-equivalent bolus, and customized lead shielding, followed by a 10 Gy boost in five daily fractions using 9-MeV electrons for residual visible disease. The treated field showed complete clinical resolution approximately one month after radiotherapy, with no in-field recurrence nearly one year later. Residual erythematous scaly plaques persisted outside the original field. This case supports response-adapted electron beam radiotherapy as a feasible non-surgical option for selected inoperable superficial EMPD and emphasizes the practical importance of pretreatment mapping, adequate field coverage, bolus conformity, shielding, and field-edge planning for extensive lesions on curved body surfaces.
